Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Borderzone Sampling [NA]
Clinical trial update noting completion of a Maastricht University Medical Center study on borderzone sampling in high-grade glioma and glio…
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) [Phase 2]
This document reports the completed Phase II trial results for bevacizumab plus erlotinib in patients with recurrent malignant glioma, inclu…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas
This completed clinical trial investigates a protocol to distinguish tumor recurrence from treatment-related necrosis in patients with recur…
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma [Phase 2]
Phase 2 study of Gamma Knife radiosurgery using MRI spectroscopy for recurrent glioblastoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma [Phase 2]
Phase 2 trial update reporting results for bevacizumab in combination with metronomic temozolomide in recurrent malignant glioma, including …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]
Phase 1 study evaluating the combination of temsirolimus, temozolomide, and radiation therapy in newly diagnosed glioblastoma; the trial sta…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating tipifarnib with radiation therapy for newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [Phase 1]
Phase 1 trial evaluating arsenic trioxide with radiation therapy in newly diagnosed malignant glioma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme [Phase 2]
Phase II trial of erlotinib plus sirolimus in recurrent malignant glioma (glioblastoma and gliosarcoma) has completed and results were poste…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572) [Phase 4]
A Phase 4 trial comparing standard Temozolomide alone to standard Temozolomide with early postoperative Temozolomide in newly diagnosed glio…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG) [Phase 2]
Phase II study of imatinib plus hydroxyurea in patients with recurrent or progressive grade II low-grade glioma; trial completed with result…
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients [Phase 2]
This Phase 2 trial evaluates sunitinib given before and during radiotherapy in patients with newly diagnosed biopsy-only glioblastoma. The s…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Evaluation of [18F]-FMISO for Non Operated Glioblastoma [Phase 2]
Phase 2 clinical trial evaluating [18F]-FMISO PET imaging for non-operated glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG [Phase 1]
A Phase I trial evaluating imatinib (Gleevec) in combination with everolimus (RAD001) and hydroxyurea in patients with recurrent glioblastom…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas [Phase 1]
A Phase I trial evaluated adding a Farnesyl Transferase Inhibitor to temozolomide in patients with Grade 3-4 malignant gliomas, and the stud…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas [Phase 1]
Phase I dose-escalation study of Vandetanib in combination with Etoposide for malignant gliomas (glioblastoma and gliosarcoma) has completed…
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas [Phase 1]
A Phase 1 clinical trial evaluating the combination of Carmustine wafers and Irinotecan for patients with recurrent supratentorial high-grad…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: RO4929097 in Treating Patients With Recurrent Invasive Gliomas [Phase 1]
Phase 1 trial update for RO4929097 in recurrent invasive gliomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan [Phase 2]
Phase II trial evaluating bevacizumab with temozolomide or etoposide in glioblastoma or gliosarcoma patients who progressed after bevacizuma…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Bortezomib in Treating Patients With Recurrent Glioma [Phase 1]
Phase 1 trial evaluating bortezomib in adults with recurrent glioma; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant plus adjuvant fenretinide versus adjuvant fenretinide alone in patients undergoing surgery for…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas [Phase 2]
Phase 2 trial evaluating Avastin with radiation and temozolomide, followed by Avastin, temozolomide and irinotecan in glioblastoma and glios…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma [Phase 2]
Phase 2 clinical trial evaluating Avastin with radiation and temozolomide, followed by Avastin/temozolomide/topotecan in glioblastoma patien…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [Phase 1]
Phase 1 clinical trial evaluating erlotinib in patients with solid tumors and liver or kidney dysfunction has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors [Phase 1]
This document is a terminated Phase 1 trial update evaluating PET imaging with 18F-EF5 to measure oxygenation in brain tumor cells of adults…